Market closed
Perrigo/$PRGO
14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX
About Perrigo
Perrigo is one of the largest consumer health companies in the world. Since 2018, Perrigo divested its animal health and generic pharmaceuticals businesses to solely focus on consumer self-care. In North America (two thirds of total sales), the firm's product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS. Perrigo also plays in Europe, Australia, and parts of Asia where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.
Ticker
$PRGO
Sector
Trading on
NYSE
Industry
Pharmaceuticals
Headquarters
Dublin, Ireland
Employees
9,140
Website
Perrigo Metrics
BasicAdvanced
$3.5B
Market cap
-
P/E ratio
-$1.17
EPS
0.48
Beta
$1.10
Dividend rate
4.29%
Dividend yield
Price and volume
Market cap
$3.5B
Beta
0.48
52-week high
$34.60
52-week low
$23.89
Average daily volume
1.4M
Dividend rate
$1.10
Financial strength
Current ratio
2.556
Quick ratio
1.551
Long term debt to equity
98.947
Total debt to equity
109.255
Interest coverage (TTM)
1.03%
Management effectiveness
Return on assets (TTM)
1.38%
Return on equity (TTM)
-3.16%
Valuation
Price to revenue (TTM)
0.802
Price to book
0.77
Price to tangible book (TTM)
-2.32
Price to free cash flow (TTM)
22.492
Dividend yield (TTM)
4.29%
Forward dividend yield
4.29%
Growth
Revenue change (TTM)
-5.63%
Earnings per share change (TTM)
3,742.31%
3-year revenue growth (CAGR)
2.43%
3-year earnings per share growth (CAGR)
-14.90%
3-year dividend per share growth (CAGR)
5.79%
What the Analysts think about Perrigo
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for Perrigo stock.
Perrigo Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
Perrigo Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Perrigo News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Perrigo stock?
Perrigo (PRGO) has a market cap of $3.5B as of December 22, 2024.
What is the P/E ratio for Perrigo stock?
The price to earnings (P/E) ratio for Perrigo (PRGO) stock is 0 as of December 22, 2024.
Does Perrigo stock pay dividends?
Yes, the Perrigo (PRGO) stock pays dividends to shareholders. As of December 22, 2024, the dividend rate is $1.104 and the yield is 4.29%. Perrigo has a payout ratio of 0% on a trailing twelve-month basis.
When is the next Perrigo dividend payment date?
The next Perrigo (PRGO) dividend payment date is unconfirmed.
What is the beta indicator for Perrigo?
Perrigo (PRGO) has a beta rating of 0.48. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.